title: An unusual manifestation in a patient with Neurofibromatosis type 1.
authors.affiliation: Department of Dermatology, "Sapienza" University of Rome, Policlinico Umberto I, Rome, Italy - emanuele.miraglia@hotmail.it.
authors.forename: Emanuele
authors.initials: E
authors.lastname: Miraglia
authors.forename: Chiara
authors.initials: C
authors.lastname: Iacovino
authors.forename: Carmen
authors.initials: C
authors.lastname: Cantisani
authors.forename: Stefano
authors.initials: S
authors.lastname: Calvieri
authors.forename: Sandra
authors.initials: S
authors.lastname: Giustini
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001856:Bone Marrow Examination / Q000379:methods; D003520:Cyclophosphamide / Q000008:administration & dosage; D003937:Diagnosis, Differential; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009456:Neurofibromatosis 1 / Q000150:complications*; D000069283:Rituximab / Q000008:administration & dosage; D016896:Treatment Outcome; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives
chemical_list: D000069283:Rituximab; D003520:Cyclophosphamide; D014740:Vidarabine; C024352:fludarabine